News

A next-generation pneumococcal conjugate vaccine, PCV20, a single-dose protection is now available in India marking a new ...
Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...
Pfizer’s PCV20 offers single-shot protection against 20 pneumococcal serotypes, safeguarding adults from serious respiratory ...
Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes, including both invasive and non ...
ADMA Biologics' recent Q2 report showed that the company is working on enhancing its plasma yields by over 20% in IG output.
The global pneumonia diagnostics market is on track for steady expansion, with market value projected to grow from USD 613.6 ...
Vaxcyte (NASDAQ:PCVX), a biotechnology company specializing in next-generation vaccines, reported its second quarter 2025 results on August 6, 2025. The company reported a GAAP ne ...
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
The Health Ministry updated that the child had been hospitalized in recent weeks on an ECMO heart-lung machine. Israel’s ...
Scientists identify key antibodies in children that could lead to a Strep A vaccine, offering hope to save 500,000 lives ...
Liver abscesses may sound rare, but knowing the symptoms, causes, and treatments can make all the difference. From fever to abdominal pain, early diagnosis and timely care are vital. Learn all you ...